I dont think we should fear a cap raise, ever. The work behind the scenes will have us with 4 drugs in trials within 4 years, and one probably selling at $1B pa. We will be valued then at 5B even if only a quarter of the value of the first drug is reflected.
To get there worst case we would need about another $75m, but lets call it 100 m simplicity. That would mean a 50% dilution from here.
But a mcap of $5B from 200m is 25x, and remember that is conservative in so many ways, so each $1000 worth of shares now will be worth 25000 /2 = or $12,500 . If one has a 100k in shares that will have moved to 1.25M $
Let’s see what happens. I’ll turn 70 that year and try to dig this post up on my August birthday! If the platform is validated and the other drugs keep on being proved up then multiples of these numbers should apply.
PYC Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)